Connect with us

Hi, what are you looking for?

Monday, May 18, 2026

Mugglehead Investment Magazine

Alternative investment news based in Vancouver, B.C.

Mugglehead Investment Magazine

All posts tagged "bioAffinity Technologies"

PrognomiQ shares promising early results from novel lung cancer blood test

PrognomiQ shares promising early results from novel lung cancer blood test

Medical and Pharmaceutical

PrognomiQ shares promising early results from novel lung cancer blood test

Promising, but the findings are derived from a small study

Rowan Dunne5 days ago

Guardant Health and Zydus Lifesciences to launch 'Shield' multi-cancer test in India

Guardant Health and Zydus Lifesciences to launch 'Shield' multi-cancer test in India

Medical and Pharmaceutical

Guardant Health and Zydus to launch ‘Shield’ multi-cancer test in India

The development complements a collaboration the companies initiated in 2023

Rowan DunneMay 6, 2026

Ohio's 'Breath of Hope' Gala raises money for lung cancer research

Ohio's 'Breath of Hope' Gala raises money for lung cancer research

Medical and Pharmaceutical

Ohio’s ‘Breath of Hope’ Gala raises money for lung cancer research

The event has generated over US$1.6 million since 2015

Rowan DunneApril 30, 2026

New Orleans lung cancer survivor advocates for low-dose CT scans in new book

New Orleans lung cancer survivor advocates for low-dose CT scans in new book

Health & Wellness

American lung cancer survivor advocates for low-dose CT scans in new book

She held a book signing for 'One Scan Saved My Life' this week

Rowan DunneApril 2, 2026

bioAffinity Technologies soars on Monday as non-invasive lung cancer tech gains traction

bioAffinity Technologies soars on Monday as non-invasive lung cancer tech gains traction

Medical and Pharmaceutical

bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction

Shares rose by 73% during the session with no immediate catalyst

Rowan DunneMarch 23, 2026

bioAffinity launches 2,000-patient study for noninvasive lung cancer test

bioAffinity launches 2,000-patient study for noninvasive lung cancer test

Medical and Pharmaceutical

bioAffinity launches 2,000-patient study for noninvasive lung cancer test

The test analyzes sputum samples using flow cytometry to identify cancer-related cellular changes

Joseph MortonMarch 11, 2026

BioMark Diagnostics receives Innovation Award for lung cancer screening project

BioMark Diagnostics receives Innovation Award for lung cancer screening project

Medical and Pharmaceutical

BioMark Diagnostics receives Innovation Award for lung cancer screening project

It acknowledges the company’s development of an efficacious blood biopsy

Rowan DunneDecember 3, 2025

Boosting U.S. lung cancer screening uptake could save 62,000 lives in 5 years

Boosting U.S. lung cancer screening uptake could save 62,000 lives in 5 years

Medical and Pharmaceutical

Boosting U.S. lung cancer screening uptake could save 62,000 lives in 5 years

The finding was highlighted in a JAMA article on Nov. 19

Rowan DunneNovember 24, 2025

Guardant Health becomes key backer for lung cancer screening awareness campaign

Guardant Health becomes key backer for lung cancer screening awareness campaign

Medical and Pharmaceutical

Guardant Health backs lung cancer screening advocacy campaign

The aim is to enhance public understanding about proper screening and biomarker testing diligence

Rowan DunneSeptember 30, 2025

bioAffinity Technologies obtains Canadian patent for lung cancer spit test

bioAffinity Technologies obtains Canadian patent for lung cancer spit test

Medical and Pharmaceutical

bioAffinity Technologies obtains Canadian patent for lung cancer spit test

The CyPath Lung screening tool is also patented in China, Australia and Japan

Rowan DunneJuly 22, 2025

More Posts

Page 1 of 212